ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Educational Strategies On Mammography, Not Guidelines, To Come From NCAB

February 28, 1997

Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk

April 29, 2011

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Cooperative group chairman suggest changes to incentive system.

August 13, 2004

Wisconsin Funds State Cancer Control Program

July 15, 1988

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011